
### [MONDO:0017774](http://purl.obolibrary.org/obo/MONDO_0017774)
**Label:** hypobetalipoproteinemia

**Subclasses:** [MONDO:0008692](http://purl.obolibrary.org/obo/MONDO_0008692) (abetalipoproteinemia), [MONDO:0014252](http://purl.obolibrary.org/obo/MONDO_0014252) (familial hypobetalipoproteinemia 1), [MONDO:0011505](http://purl.obolibrary.org/obo/MONDO_0011505) (familial hypobetalipoproteinemia 2), [MONDO:0009528](http://purl.obolibrary.org/obo/MONDO_0009528) (chylomicron retention disease), 

**Mapped go classes:** [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0034197](http://purl.obolibrary.org/obo/GO_0034197) (triglyceride transport), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0009395](http://purl.obolibrary.org/obo/GO_0009395) (phospholipid catabolic process), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0051005](http://purl.obolibrary.org/obo/GO_0051005) (negative regulation of lipoprotein lipase activity), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0070328](http://purl.obolibrary.org/obo/GO_0070328) (triglyceride homeostasis), [GO:0034185](http://purl.obolibrary.org/obo/GO_0034185) (apolipoprotein binding), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0045540](http://purl.obolibrary.org/obo/GO_0045540) (regulation of cholesterol biosynthetic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0072574](http://purl.obolibrary.org/obo/GO_0072574) (hepatocyte proliferation), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0031983](http://purl.obolibrary.org/obo/GO_0031983) (vesicle lumen), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0042158](http://purl.obolibrary.org/obo/GO_0042158) (lipoprotein biosynthetic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0042953](http://purl.obolibrary.org/obo/GO_0042953) (lipoprotein transport), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0010519](http://purl.obolibrary.org/obo/GO_0010519) (negative regulation of phospholipase activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0030127](http://purl.obolibrary.org/obo/GO_0030127) (COPII vesicle coat), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0045834](http://purl.obolibrary.org/obo/GO_0045834) (positive regulation of lipid metabolic process), [GO:0009306](http://purl.obolibrary.org/obo/GO_0009306) (protein secretion), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0007006](http://purl.obolibrary.org/obo/GO_0007006) (mitochondrial membrane organization), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0010886](http://purl.obolibrary.org/obo/GO_0010886) (positive regulation of cholesterol storage), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0070971](http://purl.obolibrary.org/obo/GO_0070971) (endoplasmic reticulum exit site), [GO:0010884](http://purl.obolibrary.org/obo/GO_0010884) (positive regulation of lipid storage), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0044233](http://purl.obolibrary.org/obo/GO_0044233) (ER-mitochondrion membrane contact site), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0055090](http://purl.obolibrary.org/obo/GO_0055090) (acylglycerol homeostasis), [GO:0006642](http://purl.obolibrary.org/obo/GO_0006642) (triglyceride mobilization), [GO:0055091](http://purl.obolibrary.org/obo/GO_0055091) (phospholipid homeostasis), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0005548](http://purl.obolibrary.org/obo/GO_0005548) (phospholipid transporter activity), [GO:0015909](http://purl.obolibrary.org/obo/GO_0015909) (long-chain fatty acid transport), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0016050](http://purl.obolibrary.org/obo/GO_0016050) (vesicle organization), [GO:0004857](http://purl.obolibrary.org/obo/GO_0004857) (enzyme inhibitor activity), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0004859](http://purl.obolibrary.org/obo/GO_0004859) (phospholipase inhibitor activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0050996](http://purl.obolibrary.org/obo/GO_0050996) (positive regulation of lipid catabolic process), [GO:0034383](http://purl.obolibrary.org/obo/GO_0034383) (low-density lipoprotein particle clearance), [GO:0035473](http://purl.obolibrary.org/obo/GO_0035473) (lipase binding), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0007586](http://purl.obolibrary.org/obo/GO_0007586) (digestion), [GO:0006497](http://purl.obolibrary.org/obo/GO_0006497) (protein lipidation), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0000266](http://purl.obolibrary.org/obo/GO_0000266) (mitochondrial fission), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0015914](http://purl.obolibrary.org/obo/GO_0015914) (phospholipid transport), [GO:0030299](http://purl.obolibrary.org/obo/GO_0030299) (intestinal cholesterol absorption), [GO:0034377](http://purl.obolibrary.org/obo/GO_0034377) (plasma lipoprotein particle assembly), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0010744](http://purl.obolibrary.org/obo/GO_0010744) (positive regulation of macrophage derived foam cell differentiation), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0034374](http://purl.obolibrary.org/obo/GO_0034374) (low-density lipoprotein particle remodeling), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle), [GO:0006071](http://purl.obolibrary.org/obo/GO_0006071) (glycerol metabolic process), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0061024](http://purl.obolibrary.org/obo/GO_0061024) (membrane organization), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle), [GO:0009743](http://purl.obolibrary.org/obo/GO_0009743) (response to carbohydrate), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0003400](http://purl.obolibrary.org/obo/GO_0003400) (regulation of COPII vesicle coating), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0031528](http://purl.obolibrary.org/obo/GO_0031528) (microvillus membrane), [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane), [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility), [GO:0001579](http://purl.obolibrary.org/obo/GO_0001579) (medium-chain fatty acid transport), [GO:0012506](http://purl.obolibrary.org/obo/GO_0012506) (vesicle membrane), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0012507](http://purl.obolibrary.org/obo/GO_0012507) (ER to Golgi transport vesicle membrane), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), [GO:0034359](http://purl.obolibrary.org/obo/GO_0034359) (mature chylomicron), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 54.38%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) 52.13%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.06%
- [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron) 51.06%
- [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle) 51.06%
- [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle) 51.06%
- [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle) 51.06%
- [GO:0034359](http://purl.obolibrary.org/obo/GO_0034359) (mature chylomicron) 51.06%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.06%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) 48.98%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 48.98%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 48.98%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 48.98%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 48.98%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 48.98%


